Characteristics | PLWH + T2DM All age groups (N = 798) | OALWH + T2DM (n = 564) | YALWH + T2DM (n = 234) | Pearson Chi Square or Fisher Exact a(OALWH + T2DM, YALWH + T2DM) |
---|---|---|---|---|
Age (years) mean ± SD | 55.01 ± 8.96 | 59.35 ± 7.22 (70.7%) | 44.56 ± 5.10 (29.3%) | |
Gender | 0.01** | |||
Male | 618 (77.4%) | 451 (80%) | 167 (71.4%) | |
Female | 180 (22.6%) | 113 (20%) | 67 (28.6%) | |
Race/ethnicity | N = 794 | N = 560 | 0.001*** | |
White—non-Hispanic | 326 (41.1%) | 253 (45.2%) | 73 (31.2%) | |
White—Hispanic | 98 (12.3%) | 62 (11.1%) | 36 (15.4%) | |
African American—non-Hispanic | 320 (40.3%) | 214 (38.2%) | 106 (45.3%) | |
African American—Hispanic | 3 (0.4%) | 0 (0%) | 3 (1.3%) | |
Hispanic | 18 (2.3%) | 12 (2.1%) | 6 (2.6%) | |
Others | 29 (3.7%) | 19 (3.4%) | 10 (4.3%) | |
Missed visits (count) | Range: 0–12 | Range: 0–5 | Range: 0–12 | 0.23 |
Mean ± SD | 0.29 ± 0.90 | 0.24 ± 0.66 | 0.41 ± 1.30 | |
Zero | 667 (83.6%) | 476 (84.4%) | 191 (81.6%) | |
One | 84 (10.5%) | 61 (10.8%) | 23 (9.8%) | |
Two | 27 (3.4%) | 16 (2.8%) | 11 (4.7%) | |
≥ Three | 20 (2.4%) | 11 (2%) | 9 (3.7%) | |
Missed visits (dichotomous) | 0.35 | |||
No missed visits | 667 (83.6%) | 476 (84.4%) | 191 (81.6%) | |
At least one missed visit | 1 (16.4%) | 88 (15.6%) | 43 (18.4%) | |
Visit attendance | Range: 0–26 days | Range: 0–26 days | Range: 0–26 days | 0.01** |
Mean ± SD | 3.07 ± 2.517 | 3.05 ± 2.417 | 3.12 ± 2.747 | |
Visit adherence | 0.06 | |||
Mean ± SD | 0.904 ± 0.24 | 0.910 ± 0.23 | 0.890 ± 0.25 | |
0–24% | 33 (4.1%) | 23 (4.1%) | 10 (4.3%) | |
25–49% | 15 (1.8%) | 12 (2.1%) | 3 (1.3%) | |
50–74% | 62 (7.9%) | 34 (6%) | 28 (11.6%) | |
75–99% | 47 (5.9%) | 37 (6.6%) | 10 (4.2%) | |
100% | 641 (80.3%) | 458 (81.2%) | 183 (78.2%) | |
4-month visit constancy (intervals with ≥ 1 kept visit) | n = 772 | n = 546 | n = 226 | 0.67 |
Zero | 7 (0.9%) | 5 (0.9%) | 2 (0.9%) | |
One | 207 (26.8%) | 143 (26.2%) | 64 (28.3%) | |
Two | 334 (43.3%) | 244 (44.7%) | 90 (39.8%) | |
Three | 224 (29%) | 154 (28.2%) | 70 (31%) | |
6-month gap (≥ 189 days between sequential kept visits) | n = 606 | n = 425 | n = 181 | 0.19 |
Retained | 570 (94.1%) | 396 (93.2%) | 174 (96.1%) | |
Not retained | 36 (5.9%) | 29 (6.8%) | 7 (3.9%) | |
HRSA HAB measure (2 kept visits > 90 days apart) | n = 606 | n = 425 | n = 181 | 0.39 |
Retained | 418 (69%) | 298 (70.1%) | 120 (66.3%) | 0.07 |
Not retained | 188 (31%) | 127 (29.9%) | 61 (33.7%) | |
HbA1c level | n = 179 | n = 179 | n = 179 | 0.07 |
Mean ± SD | 7.565 ± 1.93 | 7.529 ± 1.90 | 7.69 ± 2.03 | |
≤ 6.5% | 64 (35.8%) | 50 (36%) | 14 (35%) | |
> 6.5% | 115 (64.2%) | 89 (64%) | 26 (65%) | |
CD4 count | n = 194 | n = 151 | n = 43 | 0.61 |
Mean ± SD | 717.84 ± 407.42 | 696.44 ± 387.06 | 792.98 ± 469.35 | |
≥ 500 cells/μL | 132 (68%) | 102 (67.5%) | 30 (69.8%) | |
200–499 cells/MlμL | 49 (25.3%) | 40 (26.5%) | 9 (20.9%) | |
< 200 cells/μL | 13 (6.7%) | 9 (6%) | 4 (9.3%) |